Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.56 -0.10 (-6.02%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Net Equity Issued and Repurchased (2020 - 2024)

Updated

Cardiol Therapeutics (CRDL) reported Net Equity Issued and Repurchased of $24,521 for FY2025, down 81.1% from $129,653 in FY2024.

Analysis

Cardiol Therapeutics (CRDL) Net Equity Issued and Repurchased (2020 - 2024) Analysis & Trends

Dating back to FY2020, Cardiol Therapeutics' Net Equity Issued and Repurchased record includes 4 years.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -29.1% (FY2020 to FY2025).
  • According to Business Quant data, Net Equity Issued and Repurchased came in at $129,653 in FY2024 and $2.26 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Cardiol Therapeutics 166.43 Mn 166.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 63,838.07
Mar 31, 2024 66,936.39
Sep 30, 2021 102,346.93
Jun 30, 2021 84,281.41
Mar 31, 2021 2.06 Mn
Dec 31, 2020 72,086.26
API Access

Cardiol Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRDL&period=max&api_key=YOUR_API_KEY